Rating History for Eli Lilly (lly) by HSBC
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/17/2026 | Rajesh Kumar | Downgrade | Reduce (Hold) |
850.00 (1,070.00) |
985.08 (1180.16) |
19.8% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/17/2026 | Rajesh Kumar | Downgrade | Reduce (Hold) |
850.00 (1,070.00) |
985.08 (1180.16) |
19.8% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||